Indolent relapse after initial aggressive B-cell lymphoma: a single institution experience in the rituximab era.

Saved in:
Bibliographic Details
Title: Indolent relapse after initial aggressive B-cell lymphoma: a single institution experience in the rituximab era.
Authors: Fasser D; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia.; The University of Western Australia Medical School, Perth, Australia., Lewis K; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Leslie C; Department of Anatomical Pathology, PathWest Laboratory Medicine, Nedlands, Australia., Cull G; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Radeski D; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Augustson B; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Howman R; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Joske D; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Crawford J; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Grove C; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Cheah CY; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia.; The University of Western Australia Medical School, Perth, Australia.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Feb; Vol. 66 (2), pp. 345-348. Date of Electronic Publication: 2024 Oct 18.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1029-2403
DOI:10.1080/10428194.2024.2416563